Zeatin prevents amyloid β-induced neurotoxicity and scopolamine-induced cognitive deficits

Journal of Medicinal Food

Volumn 12, Issue 2, 2009, Pages 271-277

  Choi, Soo Jung ^a   Jeong, Chang Ho ^b   Choi, Sung Gil ^b   Chun, Ji Yeon ^c   Kim, Young Jun ^a   Lee, Jeongmin ^d   Shin, Dong Hoon ^a   Heo, Ho Jin ^b  

^a Korea University   (South Korea)

^b Gyeongsang National University   (South Korea)

^c Sunchon National University   (South Korea)

^d Kyung Hee University   (South Korea)

Author keywords

Neurotoxicity; Scopolamine; Zeatin

Indexed keywords

AMYLOID BETA PROTEIN; SCOPOLAMINE; ZEATIN;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CLINICAL EVALUATION; CONTROLLED STUDY; IN VIVO CULTURE; INSTITUTE FOR CANCER RESEARCH MOUSE; LATENT PERIOD; LEARNING; MALE; MAZE TEST; MEMORY; MOUSE; NEUROTOXICITY; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL;

ALZHEIMER DISEASE; AMNESIA; AMYLOID BETA-PROTEIN; ANIMALS; ANTIOXIDANTS; BEHAVIOR, ANIMAL; BRAIN; CHOLINERGIC ANTAGONISTS; COGNITION DISORDERS; LEARNING; LIPID PEROXIDATION; MEMORY; MICE; MICE, INBRED ICR; MORUS; NEUROTOXICITY SYNDROMES; PC12 CELLS; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; PROTECTIVE AGENTS; RATS; REACTIVE OXYGEN SPECIES; SCOPOLAMINE; ZEATIN;

MUS;

EID: 67649525158     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2007.0678     Document Type: Article

References (39)

1. Selkoe DJ: Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 1999;399:A23-A31.
2. Yankner BA: Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 1996;16:921-932.
3. Hardy JA, Higgins GA: Alzheimer's disease: the amyloid cascade hypothesis. Science 1992;256:184-185.
4. Selkoe DJ: Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 2001;81:741-766.
5. Canevari L, Abramov AY, Duchen MR: Toxicity of amyloid beta peptide: tales of calcium, mitochondria, and oxidative stress. Neurochem Res 2004;29:637-650.
6. Pike CJ, Walenzcewicz AJ, Glabe CG, Cotman CW: In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res 1991;563:311-314.
7. Benzi G, Moretti A: Are reactive oxygen species involved in Alzheimer's disease? Neurobiol Aging 1995;16:661-674.
8. Mattson MP, Guo Q, Furukawa K, Pedersen WA: Presenilins, the endoplasmic reticulum, and neuronal apoptosis in Alzheimer's disease. J Neurochem 1998;70:1-14.
9. Pappolla MA, Chyan YJ, Omar RA, Hsiao K, Perry G, Smith MA, Bozner P: Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo. Am J Pathol 1998;152:871-877.
10. Marcus DL, Thomas C, Rodriguez C, Simberkoff K, Tsai JS, Strafaci JA, Freedman ML: Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp Neurol 1998;150:40-44.
11. Markesbery WR, Carney JM: Oxidative alterations in Alzheimer's disease. Brain Pathol 1999;9:133-146.
12. Smith MA, Rudnicka-Nawrot M, Richey PL, Praprotnik D, Mul-vihill P, Miller CA, Sayre LM, Perry G: Carbonyl related post-translational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease. J Neurochem 1995;64:2660-2666.
13. Branchi I, Campolongo P, Alleva E: Scopolamine effects on ultrasonic vocalization emission and behavior in the neonatal mouse. Behav Brain Res 2004;151:9-16.
14. Banowetz GM, Ammar K, Chen DD: Temperature effect on cy-tokinin accumulation and kernel mass in dwarf wheat. Ann Bot 1999;83:303-307.
15. Heo HJ, Hong SC, Cho HY, Hong BS, Kim HK, Kim EK, Shin DH: Inhibitory effect of zeatin, isolated from Fiatoua villosa, on acetylcholinesterase activity from PC12 cells. Mol Cells 2002; 13:113-117.
16. Eastwood MA: Interaction of dietary antioxidants in vivo: how fruit and vegetables prevent disease? QJM 1999;92:527-530.
17. Fotsis T, Pepper MS, Aktas E, Breit S, Rasku S, Adlercreutz H, Wahala K, Montesano R, Schweigerer L: Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res 1997;57:2916-2921.
18. Gerritsen ME: Flavonoids inhibitors of cytokine induced gene expression. In: Flavonoids in the Living System (Manthey J, Buslig B, eds.). Plenum Press, New York, 1998, pp. 183-190.
19. Middleton E Jr: Effect of plant flavonoids on immune and inflammatory cell function. Adv Exp Med Biol 1998;439:175-182.
20. Chan WH, Wu HJ: Anti-apoptotic effects of curcumin on photosensitized human epidermalcarcinoma A431 cells. J Cell Biochem 2004;92:200-212.
21. Heo HJ, Cho HY, Hong BS, Kim HK, Kim EK, Kim BK, Shin DH: Protective effect of 4′,5-dihydroxy-3′,6,7-trimethoxyflavone from Artemisia asiatica against Aβ induced oxidative stress in PC12 cells. Amyloid 2001;8:194-201.
22. +/-) mice. Chem Biol Interact 2008;175:131-134.
23. Park CH, Kim SH, Choi W, Lee YJ, Kim JS, Kang SS, Suh YH: Novel acetylcholinesterase and antiamnesic activities of dehy-droevodiamine, a constituent of Evodia rutaecarpa. Planta Med 1996;62:405-409.
24. Heo HJ, Park YJ, Suh YM, Choi SJ, Kim MJ, Cho HY, Chang YJ, Hong BS, Kim HK, Kim EK, Kim CJ, Kim BK, Shin DH: Effects of oleamide on cholineacetyltransferase and cognitive activities. Biosci Biotech Biochem 2003;67:1284-1291.
25. Donovan FM, Pike CJ, Cotman CW, Cunningham DD: Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and Rho A activities. J Neurosci 1997;17:5316-5326.
26. Harris ME, Hensley K, Butterfield DA, Leedle RA, Carney JM: Direct evidence of oxidative injury produced by the Alzheimer beta-amyloid peptide (1-40) in cultured hippocampal neurons. Exp Neurol 1995;131:193-202.
27. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stem D, Schmidt AM: RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 1996;382:685-691.
28. Behl C, Davis JB, Lesley R, Schubert D: Hydrogen peroxide mediates amyloid β protein toxicity. Cell 1994;77:817-827.
29. Gue M, Bravard A, Meunier J, Veyrier R, Gaillet S, Recasens M, Maurice T: Sex differences in learning deficits induced by prenatal stress in juvenile rats. Behav Brain Res 2004;150: 149-157.
30. Grundman M, Grundman M, Delaney P: Antioxidant strategies for Alzheimer's disease. Proc Nutr Soc 2002;61:191-202.
31. Behl C, Lezoualch F, Trapp T, Widmann M, Skutella T, Hols-boer F: Glucocorticoids enhance oxidative stress induced cell death in hippocampal neurons in vitro. Endocrinology 1997;138: 101-106.
32. Hensley K, Aksenova M, Carney JM, Butterfield DA: Amyloid-β peptide spin trapping II: evidence for decomposition of the PBN spin adduct. Neuroreport 1995;6:489-493.
33. Price P, McMillan TJ: Use of the tetrazolium assay in measuring the response of human tumor cells to ionizing radiation. Cancer Res 1990;50:1392-1396.
34. Shoffner JM, Brown MD, Torroni A, Lott MT, Cabell MF, Mirra SS, Beal MF, Yang CC, Gearing M, Salvo R: Mitochondrial DNA variants observed in Alzheimer's disease and Parkinson disease patients. Genomics 1993;17:171-184.
35. Floyd RA, Carney JM: Free radical damage to protein and DNA: mechanisms involved and relevant observations on brain undergoing oxidative stress. Ann Neurol 1992;32(Suppl):S22-S27.
36. Kasa P, Rakonczay Z, Gulya K: The cholinergic system in Alzheimer's disease. Prog Neurobiol 1997;52:511-535.
37. Kasa P Sr, Papp H, Kasa P Jr, Pakaski M, Balaspiri L: Effects of amyloid-beta on cholinergic and acetylcholinesterase-positive cells in cultured basal forebrain neurons of embryonic rat brain. Brain Res 2004;998:73-82.
38. Alvarez A, Alarcón R, Opazo C, Campos EO, Muñoz FJ, Calderón FH, Dajas F, Gentry MK, Doctor BP, De Mello FG, Inestrosa NC: Stable complex involving acetylcholinesterase and amyloid-β peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzhemer's disease. J Neurosc 1998;18:3213-3223.
39. Broadwell RD, Ofroniew MV: Serum proteins bypass the blood-brain fluid barriers for extra-cellular entry to the central nervous system. Exp Neurol 1993;120:245-263.